Related Experiment Video
Updated: Aug 7, 2025

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
A glimpse into the future of the percutaneous treatment of coronary chronic total occlusions
Gianluca Castaldi1, Alice Benedetti1, Carlo Zivelonghi1
1Hartcentrum Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp, Belgium.
Insights
Coronary chronic total occlusion (CTO) percutaneous coronary intervention (PCI) faces challenges, especially post-coronary artery bypass graft (CABG). This review explores strategies, physiology
Area of Science:
- Interventional Cardiology
- Cardiovascular Imaging
- Vascular Biology
Background:
- Coronary chronic total occlusion percutaneous coronary intervention (CTO PCI) is complex, particularly in patients with prior coronary artery bypass graft (CABG).
- Optimal strategies for post-CABG CTOs and the role of physiological assessment remain areas of active investigation.
- Current clinical practice and training for CTO PCI often overlook the potential of coronary computed tomography angiography (CCTA) for procedural planning.
Purpose of the Study:
- To address key challenges and unanswered questions in CTO PCI.
- To explore the utility of coronary computed tomography angiography (CCTA) for enhancing periprocedural planning in CTO PCI.
- To evaluate the potential of minimizing stent implantation in CTO PCI to reduce late adverse events.
Main Methods:
- Review of current literature and clinical practice regarding CTO PCI strategies.
- Analysis of the role of physiological assessment in CTO PCI.
- Exploration of advanced imaging techniques, including CCTA, for procedural planning.
- Discussion of novel approaches, such as metal-free strategies, in CTO PCI.
Main Results:
- Post-CABG CTOs present unique challenges requiring tailored strategies.
- Physiological assessment may offer valuable insights but is limited by procedural complexity.
- Coronary computed tomography angiography (CCTA), with appropriate expertise, can significantly improve procedural planning for CTO PCI.
- Minimizing stent implantation in CTO PCI is a potential strategy to reduce late adverse events but poses technical challenges.
Conclusions:
- Further research is needed to optimize CTO PCI, especially in post-CABG patients.
- Integrating advanced imaging like CCTA into routine practice can enhance CTO PCI planning and outcomes.
- Future directions in CTO PCI may involve innovative techniques and technologies to improve efficacy and safety.
Abstract:
Percutaneous coronary intervention (PCI) of coronary chronic total occlusion (CTO PCI) is one of the most challenging but rewarding procedures in the portfolio of interventional cardiologists. Several challenges, however, still must be overcome and many questions need to be answered. After coronary artery bypass graft (CABG), disease of the conduits and concomitant progression of atherosclerotic disease to CTO of the subtended native coronary vessels are common and associated with onset of new anginal symptoms and worsening of the prognosis. Which is the best strategy for these post-CABG CTOs? Furthermore, what is the role of physiology in the setting of CTO PCI? In the last decades, many researchers tried to demystify the complex maze but technical limitations and the demanding procedure itself, for both the patient and the operator, do not allow extensive investigation of its impact on clinical practice. Can we enhance periprocedural planning of CTO PCI with a more tailored and multidimensional evaluation? Analysis of coronary computed tomography angiography (CCTA) scans is getting more and more incorporated into the clinical routine and training of interventional cardiologists but mainly focuses on structural valvular disease. Nevertheless, with the appropriate expertise, a lot of information can be derived for coronary intervention to improve procedural planning and potentially outcomes. Finally, in the era of drug-eluting stent, is there a place for strategies that minimize metal implantation in the coronaries to further reduce late-onset adverse events in CTO PCI? This approach could be attractive in CTOs due to the higher risk of target vessel failure and revascularization shown in literature but, at the same time, more challenging due to the histological and anatomical complexity of the disease. In this review, we aim to tackle these questions and concomitantly provide a vision of potential future application of new techniques and technology in CTO PCI that could allow further advancement in this field.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
06:39Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...